Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

AdAlta Ltd

1AD
Current price
0.019 AUD +0.000000000074 AUD (+0.00%)
Last closed 0.019 AUD
ISIN AU0000001AD2
Sector Healthcare
Industry Biotechnology
Exchange Australian Securities Exchange
Capitalization 11 963 619 AUD
Yield for 12 month 0.00 %
1Y
3Y
5Y
10Y
15Y
1AD
21.11.2021 - 28.11.2021

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia. Its lead product is AD-214, which is in Phase II clinical trial for the treatment of fibrosis diseases, including idiopathic pulmonary fibrosis, eye fibrosis, and fibrosis diseases of the liver, skin and kidney, as well as for the treatment of age-related macular degeneration. AdAlta Limited has collaborative partnerships with GE Healthcare Technologies Inc to develop i-body enabled PET imaging agents for use in immuno-oncology; and Carina Biotech Pty Ltd to develop CAR-T cell therapies for solid tumor. The company was incorporated in 2006 and is based in Bundoora, Australia. Address: La Trobe Institute of Molecular Science, Bundoora, VIC, Australia, 3086

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

Last Year

+3 423 254 AUD

Current Quarter

Last Quarter

+1 124 774 AUD

Current Year

-62 136 AUD

Last Year

+3 393 728 AUD

Current Quarter

-52 289 AUD

Last Quarter

+1 114 928 AUD

Key Figures 1AD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -5 232 503 AUD
Operating Margin TTM -397.91 %
PE Ratio
Return On Assets TTM -50.02 %
PEG Ratio
Return On Equity TTM -273.13 %
Wall Street Target Price
Revenue TTM 1 714 793 AUD
Book Value 0.003 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -74.7 %
Dividend Yield
Gross Profit TTM 2 954 766 AUD
Earnings per share -0.0099 AUD
Diluted Eps TTM -0.0099 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 1AD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 1AD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 1AD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 5.5008
Price Sales TTM 6.9767
Enterprise Value EBITDA -1.0634
Price Book MRQ 5.9712

Financials 1AD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 1AD

For 52 weeks

0.018 AUD 0.04 AUD
50 Day MA 0.023 AUD
Shares Short Prior Month
200 Day MA 0.024 AUD
Short Ratio
Shares Short
Short Percent